The chondrosarcoma clinical trial analysis report delivers important insights into ongoing research of 5+ pipeline chondrosarcoma drugs, clinical strategies, upcoming therapeutics, and commercial ...
Ivosidenib monotherapy led to high response rates and prolonged survival in patients with IDH1-mutated myelodysplastic syndrome (MDS).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results